1. HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt–autophagy pathway
   Le Yin et al, 2023, Human Cell CrossRef
2. RUNX1/ETO regulates reactive oxygen species (ROS) levels in t(8,21) acute myeloid leukaemia via FLT3 and RAC1
   Adam Azlan et al, 2023, Medical Oncology CrossRef
3. Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining
   Nikola Curik et al, 2021, Frontiers in Oncology CrossRef
4. High STAT5A Expression is Associated with Major Molecular Response Achievement Failure of Chronic Phase Chronic Myeloid Leukemia Patients Receiving Hydroxyurea before Imatinib: A Cross-sectional Study
   Ikhwan Rinaldi et al, 2021, Open Access Macedonian Journal of Medical Sciences CrossRef
5. Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas
   Aierpati Maimaiti et al, 2022, Frontiers in Molecular Biosciences CrossRef
6. Identifying Dysregulated lncRNA-Associated ceRNA Network Biomarkers in CML Based on Dynamical Network Biomarkers
   Junhua Xu et al, 2020, BioMed Research International CrossRef
7. STAT5B Suppresses Ferroptosis by Promoting DCAF13 Transcription to Regulate p53/xCT Pathway to Promote Mantle Cell Lymphoma Progression
   Wen Jun Zhang et al, 2024, Biologics: Targets and Therapy CrossRef
8. ZIPK collaborates with STAT5A in p53-mediated ROS accumulation in hyperglycemia-induced vascular injury
   Qichao Wu et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef